ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,781Medicare Part D Prescriptions Filled, Including Refills

Rank: 177 out of 944

$537K Total Retail Price of All Prescriptions

Rank: 178 out of 944

411 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,938 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 562 513 1 5
SIMVASTATIN 382 349 2 1
LISINOPRIL 357 337 3 3
OMEPRAZOLE 294 263 4 4
LEVOTHYROXINE SODIUM 260 235 5 2
FUROSEMIDE 249 225 6 6
ATORVASTATIN CALCIUM 241 231 7 13
LOSARTAN POTASSIUM 236 198 8 16
POLYETHYLENE GLYCOL 3350 201 178 9 41
HYDROCHLOROTHIAZIDE 199 178 10 9
METOPROLOL SUCCINATE 197 181 11 14
ATENOLOL 166 163 12 11
ZOLPIDEM TARTRATE 163 153 13 25
METOPROLOL TARTRATE 139 132 14 8
ALENDRONATE SODIUM 127 120 15 20
DOXAZOSIN MESYLATE 126 122 16 60
METFORMIN HCL 124 121 17 12
HYDROCODONE-ACETAMINOPHEN 124 94 S3 17 10
FENTANYL 120 111 S2 19 57
WARFARIN SODIUM 117 113 20 7
SYNTHROID 114 103 21 82
TRAMADOL HCL 112 108 22 21
MIRTAZAPINE 107 106 23 35
SERTRALINE HCL 107 103 23 23
TRIAMTERENE-HCTZ 98 96 25 33
GABAPENTIN 93 91 26 18
POTASSIUM CHLORIDE 93 87 26 15
CRESTOR 91 90 28 28
PANTOPRAZOLE SODIUM 87 87 29 34
FLUOXETINE HCL 87 71 29 48
DONEPEZIL HCL 81 81 31 24
CELEBREX 72 64 32 110
PRAVASTATIN SODIUM 70 67 33 17
NEXIUM 68 68 34 53
ALLOPURINOL 67 67 35 22
NAMENDA 65 65 36 37
DICLOFENAC SODIUM 61 56 37 106
DIOVAN 61 61 37 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 55 39 29
FAMOTIDINE 56 56 40 74
TRAZODONE HCL 56 45 40 45
NIFEDIPINE ER 55 51 42 148
TAMSULOSIN HCL 55 55 42 27
ACETAMINOPHEN-CODEINE 55 55 S3 42 95
BENAZEPRIL HCL 54 54 45 66
KLOR-CON M20 53 52 46 71
MICARDIS 51 51 47 369
FLUTICASONE PROPIONATE 50 39 48 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.